Loading…
CIK 0001616824 • 6 13F filings • May 7, 2025 – Aug 7, 2026
Import this data to Google Sheets with:
=jivedata("bml-capital-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC | COM | $27.1M | 24.8%Prev: 36.0% | 14,250,000 SH | Decreased+2,275,000 SH |
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | $13.9M | 12.7% | 3,057,526 SH | New |
| ALUMIS INC | COM | $4.8M | 4.4% | 1,210,415 SH | New |
| ARVINAS INC | COM | $426K | 0.4% | 50,000 SH | New |
| ASTROTECH CORP | COM | $1.1M | 1.0% | 220,410 SH | New |
| ATEA PHARMACEUTICALS INC | COM | $21.7M | 19.8%Prev: 18.4% | 7,473,963 SH | Decreased+521,633 SH |
| ATHIRA PHARMA INC | COM | $1.3M | 1.2% | 323,066 SH | New |
| CONNECT BIOPHARMA HLDGS LTD | SHS | $1.9M | 1.8%Prev: 0.8% | 1,267,500 SH | Increased+694,213 SH |
| IMAGENEBIO INC | COM | $1.5M | 1.4%Prev: 0.7% | 182,509 SH | Increased-18,221 SH |
| INSTIL BIO INC | COM NEW | $11.5M | 10.6%Prev: 2.8% | 645,600 SH | Increased |
| KEZAR LIFE SCIENCES INC | COM NEW | $2.8M | 2.6% | 720,787 SH | New |
| LAVA THERAPEUTICS NV | SHS | $3.1M | 2.8% | 1,970,610 SH | New |
| LISATA THERAPEUTICS INC | COM | $288K | 0.3% | 109,841 SH | New |
| MURAL ONCOLOGY PUB LTD CO | ORD SHS | $119K | 0.1% | 57,500 SH | New |
| ORAMED PHARMACEUTICALS INC | COM NEW | $8.4M | 7.7%Prev: 2.4% | 3,167,231 SH | Increased+2,300,962 SH |
| PMV PHARMACEUTICALS INC | COM | $7.4M | 6.8%Prev: 4.1% | 5,292,000 SH | Increased-38,000 SH |
| TARGET CORP | COM | $897K | 0.8%Prev: 2.8% | 10,000 SH | Decreased-27,500 SH |
| VISTAGEN THERAPEUTICS INC | COM | $533K | 0.5% | 150,000 SH | New |
| WALMART INC | COM | $519K | 0.5%Prev: 0.2% | 265 SH | Increased-70 SH |
| 13F-HR |
| 0001754960-26-000696 |
| $176.1M |
| View |
| Aug 11, 2025 | Q2 2025 | 13F-HR | 0001754960-25-000555 | $132.2M | View |
| May 6, 2026 | Q1 2026 | 13F-HR | 0001754960-26-000359 | $155.8M | View |
| May 7, 2025 | Q1 2025 | 13F-HR | 0001754960-25-000280 | $123.6M | View |